Morgan Stanley
SVRA icon

Morgan Stanley’s Savara SVRA Stock Holding History

Morgan Stanley’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.75M Sell
1,786,293
-551,603
-24% -$3.07M ﹤0.01% 3587
2025
Q4 		$14.1M Buy
2,337,896
+420,069
+22% +$2.06M ﹤0.01% 3271
2025
Q3 		$6.85M Buy
1,917,827
+1,535,214
+401% +$4.54M ﹤0.01% 3888
2025
Q2 		$872K Buy
382,613
+127,100
+50% +$346K ﹤0.01% 5173
2025
Q1 		$708K Sell
255,513
-140,445
-35% -$388K ﹤0.01% 5171
2024
Q4 		$1.22M Sell
395,958
-75,397
-16% -$263K ﹤0.01% 4995
2024
Q3 		$2M Buy
471,355
+214,030
+83% +$945K ﹤0.01% 4653
2024
Q2 		$1.04M Buy
257,325
+25,761
+11% +$115K ﹤0.01% 4942
2024
Q1 		$1.15M Sell
231,564
-211,456
-48% -$1.02M ﹤0.01% 4880
2023
Q4 		$2.08M Buy
443,020
+367,094
+483% +$1.41M ﹤0.01% 4898
2023
Q3 		$287K Sell
75,926
-29,274
-28% -$104K ﹤0.01% 5422
2023
Q2 		$336K Sell
105,200
-87,726
-45% -$206K ﹤0.01% 5412
2023
Q1 		$376K Sell
192,926
-26,327
-12% -$59.3K ﹤0.01% 5417
2022
Q4 		$340K Buy
219,253
+27,932
+15% +$38.3K ﹤0.01% 5431
2022
Q3 		$298K Buy
191,321
+8,168
+4% +$13.1K ﹤0.01% 5534
2022
Q2 		$278K Sell
183,153
-22,143
-11% -$29.1K ﹤0.01% 5723
2022
Q1 		$268K Sell
205,296
-114,739
-36% -$138K ﹤0.01% 5760
2021
Q4 		$397K Sell
320,035
-81,623
-20% -$97.1K ﹤0.01% 5687
2021
Q3 		$554K Sell
401,658
-23,662
-6% -$32K ﹤0.01% 5427
2021
Q2 		$723K Buy
425,320
+416,249
+4,589% +$749K ﹤0.01% 5280
2021
Q1 		$19K Sell
9,071
-41,947
-82% -$71.8K ﹤0.01% 6736
2020
Q4 		$59K Buy
51,018
+41,822
+455% +$50.4K ﹤0.01% 6111
2020
Q3 		$10K Sell
9,196
-9,225
-50% -$15.8K ﹤0.01% 6280
2020
Q2 		$46K Buy
18,421
+11,665
+173% +$28.4K ﹤0.01% 5705
2020
Q1 		$15K Sell
6,756
-50,209
-88% -$138K ﹤0.01% 5912
2019
Q4 		$255K Buy
56,965
+31,041
+120% +$37.4K ﹤0.01% 5306
2019
Q3 		$69K Buy
25,924
+13,415
+107% +$33.5K ﹤0.01% 5579
2019
Q2 		$29K Sell
12,509
-4,261
-25% -$37.9K ﹤0.01% 5819
2019
Q1 		$123K Sell
16,770
-40,940
-71% -$308K ﹤0.01% 5306
2018
Q4 		$437K Sell
57,710
-147,850
-72% -$1.33M ﹤0.01% 4867
2018
Q3 		$2.29M Buy
205,560
+142,140
+224% +$1.63M ﹤0.01% 3896
2018
Q2 		$718K Buy
63,420
+27,997
+79% +$281K ﹤0.01% 4850
2018
Q1 		$326K Sell
35,423
-848
-2% -$9.98K ﹤0.01% 5239
2017
Q4 		$538K Buy
+36,271
New +$416K ﹤0.01% 4938
2017
Q3 		– Sell
-478
Closed -$3K – 6609
2017
Q2 		$3K Buy
+478
New +$3.28K ﹤0.01% 6421
2017
Q1 		– Sell
-2,570
Closed -$16K – 6610
2016
Q4 		$16K Buy
+2,570
New +$16.2K ﹤0.01% 6052
2016
Q1 		– Sell
-561
Closed -$17K – 6709
2015
Q4 		$17K Sell
561
-2,397
-81% -$74.5K ﹤0.01% 6087
2015
Q3 		$120K Buy
2,958
+2,948
+29,480% +$94.1K ﹤0.01% 5336
2015
Q2 		$0 Hold
10
– – ﹤0.01% 6743
2015
Q1 		$0 Sell
10
-630
-98% -$21.9K ﹤0.01% 6645
2014
Q4 		$25K Buy
640
+630
+6,300% +$22K ﹤0.01% 5997
2014
Q3 		$0 Sell
10
-147
-94% -$6.18K ﹤0.01% 6657
2014
Q2 		$7K Sell
157
-12,473
-99% -$544K ﹤0.01% 6251
2014
Q1 		$601K Sell
12,630
-1,655
-12% -$90.7K ﹤0.01% 4423
2013
Q4 		$462K Buy
14,285
+2,267
+19% +$72.8K ﹤0.01% 4505
2013
Q3 		$369K Buy
12,018
+8,080
+205% +$251K ﹤0.01% 4536
2013
Q2 		$117K Buy
+3,938
New +$175K ﹤0.01% 5035

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Morgan Stanley's SVRA Position: Q1 2026 in Review

Morgan Stanley reduced its Savara (SVRA) stake by 24% in Q1 2026, selling an estimated $3.07M and leaving 1,786,293 shares worth $9.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3587.

Morgan Stanley first reported a position in SVRA in Q2 2013 and has held it in 47 quarters since. The position peaked at $14.1M in Q4 2025. 186 funds tracked by Wall St. Rank hold SVRA as of Q1 2026.

  • Morgan Stanley held 1,786,293 shares of Savara worth $9.75M as of Q1 2026.
  • Morgan Stanley sold 551,603 Savara shares in Q1 2026, an estimated $3.07M.
  • Savara made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3587 holding.
  • Morgan Stanley first reported a position in Savara in Q2 2013 and has held it in 47 quarters since.
  • Morgan Stanley's Savara position peaked at $14.1M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Savara as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.